Captrust Financial Advisors Iradimed Corp Transaction History

Captrust Financial Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$30.15 - $45.79 $9,165 - $13,920	-304 Reduced 26.88%	827 $28,000
Q4 2021 Feb 14, 2022	BUY	$32.35 - $48.27 $9,899 - $14,770	306 Added 37.09%	1,131 $52,000
Q3 2021 Nov 16, 2021	BUY	$29.5 - $37.21 $24,337 - $30,698	825 New	825 $28,000
Q1 2021 May 17, 2021	SELL	$22.3 - $26.02 $761,455 - $888,478	-34,146 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$20.62 - $25.0 $20,908 - $25,350	1,014 Added 3.06%	34,146 $779,000
Q3 2020 Nov 17, 2020	BUY	$21.0 - $24.61 $215,544 - $252,597	10,264 Added 44.88%	33,132 $711,000
Q2 2020 Aug 14, 2020	BUY	$18.68 - $24.35 $17,465 - $22,767	935 Added 4.26%	22,868 $543,000
Q1 2020 May 15, 2020	BUY	$16.08 - $27.67 $352,682 - $606,886	21,933 New	21,933 $436,000

140

6.59M

Ticker IRMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 12,565,100
Market Cap $679M
Description
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.